ER stress and diseases

被引:904
|
作者
Yoshida, Hiderou [1 ]
机构
[1] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan
关键词
conformational disease; cytoplasmic splicing; ER stress response; ER-associated protein degradation (ERAD); Golgi stress response;
D O I
10.1111/j.1742-4658.2007.05639.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteins synthesized in the endoplasmic reticulum (ER) are properly folded with the assistance of ER chaperones. Malfolded proteins are disposed of by ER-associated protein degradation (ERAD). When the amount of unfolded protein exceeds the folding capacity of the ER, human cells activate a defense mechanism called the ER stress response, which induces expression of ER chaperones and ERAD components and transiently attenuates protein synthesis to decrease the burden on the ER. It has been revealed that three independent response pathways separately regulate induction of the expression of chaperones, ERAD components, and translational attenuation. A malfunction of the ER stress response caused by aging, genetic mutations, or environmental factors can result in various diseases such as diabetes, inflammation, and neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, and bipolar disorder, which are collectively known as 'conformational diseases'. In this review, I will summarize recent progress in this field. Molecules that regulate the ER stress response would be potential candidates for drug targets in various conformational diseases.
引用
收藏
页码:630 / 658
页数:29
相关论文
共 50 条
  • [1] ER stress and neurodegenerative diseases
    Lindholm, D
    Wootz, H
    Korhonen, L
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (03): : 385 - 392
  • [2] ER stress and neurodegenerative diseases
    D Lindholm
    H Wootz
    L Korhonen
    Cell Death & Differentiation, 2006, 13 : 385 - 392
  • [3] ER stress proteins in autoimmune an inflammatory diseases
    Morito, Daisuke
    Nagata, Kazuhiro
    FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [4] Endoplasmic Reticulum (ER) Stress Response Failure in Diseases
    Bhattarai, Kashi Raj
    Chaudhary, Manoj
    Kim, Hyung-Ryong
    Chae, Han-Jung
    TRENDS IN CELL BIOLOGY, 2020, 30 (09) : 672 - 675
  • [5] Protein folding stress in neurodegenerative diseases: a glimpse into the ER
    Matus, Soledad
    Glimcher, Laurie H.
    Hetz, Claudio
    CURRENT OPINION IN CELL BIOLOGY, 2011, 23 (02) : 239 - 252
  • [6] Gene therapy to target ER stress in brain diseases
    Valenzuela, Vicente
    Martinez, Gabriela
    Duran-Aniotz, Claudia
    Hetz, Claudio
    BRAIN RESEARCH, 2016, 1648 : 561 - 570
  • [7] ER Quality Control and ER Stress-induced Cell Death in Neurodegenerative Diseases
    Nagai, Atsushi
    Kadowaki, Hisae
    Nishitoh, Hideki
    JOURNAL OF ORAL BIOSCIENCES, 2007, 49 (01): : 39 - 46
  • [8] Small molecule modulators of ER stress for the treatment of neurodegenerative diseases
    Cosford, Nicholas
    Zou, Haixia
    Limpert, Allison
    Zou, Jiwen
    Dembo, Anna
    Grant, Daniel
    Ardecky, Robert
    Pinkerton, Anthony
    Magnuson, Gavin
    Goldman, Mark
    Rong, Juan
    Sheffler, Douglas
    Reed, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [9] Unraveling the role of ER stress inhibitors in the context of metabolic diseases
    Sarvani, Chodisetty
    Sireesh, Dornadula
    Ramkumar, Kunka Mohanram
    PHARMACOLOGICAL RESEARCH, 2017, 119 : 412 - 421
  • [10] ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics
    Ajoolabady, Amir
    Wang, Shuyi
    Kroemer, Guido
    Klionsky, Daniel J.
    Uversky, Vladimir N.
    Sowers, James R.
    Aslkhodapasandhokmabad, Hamid
    Bi, Yaguang
    Ge, Junbo
    Ren, Jun
    ENDOCRINE REVIEWS, 2021, 42 (06) : 839 - 871